Medicamento autorizado
Un regulador lo ha autorizado para al menos un uso, en al menos un país. Eso no dice nada sobre usos fuera de la licencia.
Esta página es un esbozo
The wiki has this compound's identity from the My-Pepts library, its standing, and what PubMed holds for it. The article, with its studies read and cited, is not written yet. Until it is, the counts below say how much research exists, not what it found.
Qué tan sólida es la evidencia
Hasta dónde ha llegado
Todo medicamento sube la misma escalera. La mayoría de los compuestos nunca llega a lo más alto, y el lugar que ocupa indica cuánto pueden sostener sus afirmaciones.
- Medicamento autorizado: Thymosin Alpha-1
Un regulador ha revisado los ensayos y lo ha autorizado para un uso concreto.
- Fase 3
Ensayos aleatorizados grandes, a menudo con miles de personas, frente a placebo o un tratamiento estándar.
- Fase 2
Ensayos de tamaño medio que miden la dosis frente al efecto en personas con la enfermedad.
- Fase 1 y estudios humanos iniciales
Primeros estudios en personas: seguridad y cómo el organismo lo procesa.
- Células y animales
Trabajo de laboratorio y con animales. Un resultado en animales no es un resultado en personas.
- 624
- artículos en PubMed
- 375
- de ellos en personas
- 39
- ensayos aleatorizados
- 86
- revisiones
Un recuento indica cuánto se ha publicado, no lo que encontró. Contado en PubMed: 2026-11-16
Manipulación y reconstitución
Del polvo a una muestra medida
Los mismos cuatro pasos para cualquier vial liofilizado. Manipulación de laboratorio, no uso en una persona.
1. Lea el vial
La etiqueta indica la masa de péptido en el vial, en miligramos. Ese número es el punto de partida de todo cálculo.
2. Añada el diluyente
Se añade un volumen medido de diluyente lentamente, por la pared del vidrio. Haga girar con suavidad; agitar puede dañar un péptido.
3. Calcule la concentración
La concentración es la masa dividida por el volumen: 10 mg en 2 mL son 5 mg por mL.
4. Mida la muestra
El volumen es la masa deseada dividida por la concentración. En una jeringa U-100, 1 mL equivale a 100 unidades.
La calculadora de abajo hace la aritmética y muestra el procedimiento.
As powder
General practice for lyophilized peptides: keep the sealed vial frozen or refrigerated, dry and away from light, and follow the supplier's certificate of analysis.
In solution
Once in solution a peptide is kept refrigerated and used within the period the supplier states. A vial drawn from more than once needs a preserved diluent such as bacteriostatic water.
This is general practice for lyophilized peptides, not data on Thymosin Alpha-1 itself. The batch's certificate of analysis and the supplier's sheet are the facts to go by. More on storage
Reconstitution calculator
Opens on vial sizes common for research peptides. Change any number. How the arithmetic works
Draw to
10 units
0.1 mL on a U-100 syringe
- Concentration
- 2.5 mg/mL
- Each unit holds
- 25 mcg
- Samples in the vial
- 20
- Sample
- 250 mcg
5 mg in 2 mL is 2.5 mg/mL. 250 mcg of that is 0.1 mL, which reads as 10 units. This is arithmetic for a vial of Thymosin Alpha-1; no amount here is a recommendation.
Thymosin Alpha-1: en PubMed
What PubMed held for Thymosin Alpha-1 on November 16, 2026. A count says how much a compound has been studied, not what the studies found: how to read these numbers.
- 624
- papers
- 375
- in humans
- 56
- clinical trials
- 39
- randomized trials
Most relevant on PubMed
Listed by PubMed's own relevance ranking, trials and reviews first. The wiki has not read these into the article unless they are also among its sources.
- The efficacy of thymosin alpha-1 therapy in moderate to critical COVID-19 patients: a systematic review, meta-analysis, and meta-regression
Meta-analysisSoeroto AY, Suryadinata H, Yanto TA, et al. Inflammopharmacology, 2023. PMID 37845598
- Thymosin Alpha 1 Plus Routine Treatment for the Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
Meta-analysisCao A, Feng F, Zhou X Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2024. PMID 39648386
- Immune enhancement in patients with predicted severe acute necrotising pancreatitis: a multicentre double-blind randomised controlled trial
Randomized trialKe L, Zhou J, Mao W, et al. Intensive care medicine, 2022. PMID 35713670
- The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis
Meta-analysisPeng D, Xing HY, Li C, et al. BMC gastroenterology, 2020. PMID 33076834
- Comprehensive Review of the Safety and Efficacy of Thymosin Alpha 1 in Human Clinical Trials
ReviewDinetz E, Lee E Alternative therapies in health and medicine, 2024. PMID 38308608
- Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection
Meta-analysisXia Y, Luo H, Liu JP, et al. The Cochrane database of systematic reviews, 2013. PMID 23633363
- Thymosin alpha-1
ReviewAncell CD, Phipps J, Young L American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2001. PMID 11381492
- Aging and Thymosin Alpha-1
ReviewSimonova MA, Ivanov I, Shoshina NS, et al. International journal of molecular sciences, 2025. PMID 41373628
Search used: ("thymosin alpha 1"[tiab] OR "thymosin alpha-1"[tiab] OR thymalfasin[tiab]). Run it on PubMed
Enlaces de investigación
- PubMed (opens in a new tab)Every indexed paper, newest first
- ClinicalTrials.gov (opens in a new tab)Registered trials and their status
- Europe PMC (opens in a new tab)Full text where it is open access
- Google Scholar (opens in a new tab)Papers, preprints and who cites them
- PubChem (opens in a new tab)Structure, identifiers and properties
- YouTube (opens in a new tab)Talks and lectures. Check who is speaking
These open a search for Thymosin Alpha-1 on each site. The wiki has not reviewed what they return: a video or a preprint is not a peer-reviewed result, and none of it is medical advice.